Half-year report · HY
4208.TEDINET S100X0R8
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥212.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥486.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥243.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥8.3bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥6.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥15.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥22.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥14.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥318m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥613m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥865.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥865.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥796.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥441.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥453.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥424.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥412.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥420.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥44.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥116.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥44.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥115.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥31.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥88.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥63.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥33.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥16.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥105.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥19.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥112.08 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.6 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.28 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥112.06 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥3.27 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥16.7bn |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥23.6bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥6.9bn |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥2.1bn |
| High Performance Urethansreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥17.0bn |
| High Performance Urethansreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥16.8bn |
| High Performance Urethansreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥256m |
| High Performance Urethansreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥565m |
| Machinery And Metal Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥29.8bn |
| Machinery And Metal Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥29.6bn |
| Machinery And Metal Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥138m |
| Machinery And Metal Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Pharmaceuticalreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥10.5bn |
| Pharmaceuticalreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥10.5bn |
| Pharmaceuticalreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Pharmaceuticalreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥483m |
| Polymers And Chemicalsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥118.5bn |
| Polymers And Chemicalsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥107.5bn |
| Polymers And Chemicalsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥11.0bn |
| Polymers And Chemicalsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.2bn |
| Specialty Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥29.8bn |
| Specialty Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥24.7bn |
| Specialty Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.1bn |
| Specialty Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.3bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥222.3bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥212.7bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥9.6bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥10.3bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥20.7bn |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥25.0bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥4.4bn |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥13.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥13.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| High Performance Urethansreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥7.4bn |
| High Performance Urethansreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥7.1bn |
| High Performance Urethansreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥229m |
| High Performance Urethansreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥774m |
| Machinery And Metal Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥43.0bn |
| Machinery And Metal Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥42.8bn |
| Machinery And Metal Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥282m |
| Machinery And Metal Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Pharmaceuticalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥15.9bn |
| Pharmaceuticalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥15.0bn |
| Pharmaceuticalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥815m |
| Pharmaceuticalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥712m |
| Polymers And Chemicalsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥137.8bn |
| Polymers And Chemicalsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥128.7bn |
| Polymers And Chemicalsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥9.1bn |
| Polymers And Chemicalsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥2.5bn |
| Specialty Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥31.7bn |
| Specialty Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥24.4bn |
| Specialty Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Specialty Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥256.4bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥243.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥8.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 574
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses | InterimInstant | 5082000000 | JPY |
| Other provision cl | Prior1YearInstant | 671000000 | JPY |
| Other provision cl | InterimInstant | 661000000 | JPY |
| Other cl | Prior1YearInstant | 49929000000 | JPY |
| Other cl | InterimInstant | 39250000000 | JPY |
| Current liabilities | Prior1YearInstant | 197719000000 | JPY |
| Current liabilities | InterimInstant | 175690000000 | JPY |
| Bonds payable | Prior1YearInstant | 80000000000 | JPY |
| Bonds payable | InterimInstant | 90000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 155646000000 | JPY |
| Long term loans payable | InterimInstant | 152508000000 | JPY |
| Provision ncl | Prior1YearInstant | 2405000000 | JPY |
| Provision ncl | InterimInstant | 3541000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 4711000000 | JPY |
| Net defined benefit liability | InterimInstant | 5232000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 1220000000 | JPY |
| Asset retirement obligations ncl | InterimInstant | 1753000000 | JPY |
| Other ncl | Prior1YearInstant | 11955000000 | JPY |
| Other ncl | InterimInstant | 12971000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 255937000000 | JPY |
| Noncurrent liabilities | InterimInstant | 266005000000 | JPY |
| Liabilities | Prior1YearInstant | 453656000000 | JPY |
| Liabilities | InterimInstant | 441695000000 | JPY |
| Capital stock | Prior1YearInstant | 58435000000 | JPY |
| Capital stock | InterimInstant | 58435000000 | JPY |
| Capital surplus | Prior1YearInstant | 40363000000 | JPY |
| Capital surplus | InterimInstant | 40360000000 | JPY |
| Retained earnings | Prior1YearInstant | 260914000000 | JPY |
| Retained earnings | InterimInstant | 266458000000 | JPY |
| Treasury stock | Prior1YearInstant | -21486000000 | JPY |
| Treasury stock | InterimInstant | -21440000000 | JPY |
| Shareholders equity | Prior1YearInstant | 338226000000 | JPY |
| Shareholders equity | InterimInstant | 343813000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 7555000000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 10337000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 12000000 | JPY |
| Deferred gains or losses on hedges | InterimInstant | 22000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 41331000000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 45209000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 7954000000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 7304000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 56852000000 | JPY |
| Valuation and translation adjustments | InterimInstant | 62872000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 24000000 | JPY |
| Subscription rights to shares | InterimInstant | 24000000 | JPY |
| Non controlling interests | Prior1YearInstant | 16911000000 | JPY |
| Non controlling interests | InterimInstant | 17430000000 | JPY |
| Net assets | Prior1YearInstant | 412013000000 | JPY |
| Net assets | InterimInstant | 424139000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 865669000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |